BharatRohan Achieves Hyperspectral Imaging Milestone for Pharma
BharatRohan Airborne Innovations Ltd has achieved a significant internal technology milestone in applying its hyperspectral imaging platform to pharmaceutical quality screening. The company's system demonstrated the ability to non-destructively differentiate genuine pharmaceutical tablets from adulterated or substandard samples by analyzing spectral signatures. This marks an expansion of their expertise from precision agriculture into pharmaceutical quality assurance and anti-counterfeiting, opening a new addressable market. The company is currently engaged in discussions with regulatory and scientific authorities in India to explore validation and piloting pathways for this technology. While the long-term commercial potential is significant, it is contingent on further validation and regulatory acceptance. BharatRohan also operates a research and development subsidiary in the Netherlands.
Key Highlights
- Achieved internal milestone in hyperspectral imaging for pharma quality screening.
- Technology can differentiate genuine from adulterated pharmaceutical tablets.
- Expands application from agriculture to pharma, opening new market.
- Engaged in discussions with regulatory authorities for validation.
- Potential for significant long-term commercial opportunity.
Price Impact
More from BHARATROHAN